Acorah Software Products - Accounts Production 16.5.460 false true true 31 December 2023 1 January 2023 false 15 September 2025 1 January 2024 31 December 2024 31 December 2024 00857402 Mr Philip Ellin Mrs Lisa Parry Mr Dylan Jones iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 00857402 2023-12-31 00857402 2024-12-31 00857402 2024-01-01 2024-12-31 00857402 frs-core:CurrentFinancialInstruments 2024-12-31 00857402 frs-core:FurnitureFittings 2024-12-31 00857402 frs-core:FurnitureFittings 2024-01-01 2024-12-31 00857402 frs-core:FurnitureFittings 2023-12-31 00857402 frs-core:MotorVehicles 2024-12-31 00857402 frs-core:MotorVehicles 2024-01-01 2024-12-31 00857402 frs-core:MotorVehicles 2023-12-31 00857402 frs-core:ShareCapital 2024-12-31 00857402 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 00857402 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 00857402 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 00857402 frs-bus:SmallEntities 2024-01-01 2024-12-31 00857402 frs-bus:Audited 2024-01-01 2024-12-31 00857402 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 00857402 frs-core:UnlistedNon-exchangeTraded 2024-12-31 00857402 frs-core:UnlistedNon-exchangeTraded 2023-12-31 00857402 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-12-31 00857402 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-12-31 00857402 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-12-31 00857402 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-12-31 00857402 frs-bus:Director1 2024-01-01 2024-12-31 00857402 frs-bus:Director2 2024-01-01 2024-12-31 00857402 frs-bus:CompanySecretary1 2024-01-01 2024-12-31 00857402 frs-countries:EnglandWales 2024-01-01 2024-12-31 00857402 2022-12-31 00857402 2023-12-31 00857402 2023-01-01 2023-12-31 00857402 frs-core:CurrentFinancialInstruments 2023-12-31 00857402 frs-core:ShareCapital 2023-12-31 00857402 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31
Registered number: 00857402
Niagara Therapy(U.K.)Limited
Financial Statements
For The Year Ended 31 December 2024
Niagara Therapy(U.K.)Limited
Contents
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—4
Page 1
Niagara Therapy(U.K.)Limited
Balance Sheet
As At 31 December 2024
Balance Sheet
Registered number: 00857402
2024 2023
Notes £ £ £ £
FIXED ASSETS
Investments 5 2 2
2 2
CURRENT ASSETS
Debtors 6 (36,433 ) 27,302
Cash at bank and in hand 850 850
(35,583 ) 28,152
Creditors: Amounts Falling Due Within One Year 7 (3,688,852 ) (3,396,952 )
NET CURRENT ASSETS (LIABILITIES) (3,724,435 ) (3,368,800 )
TOTAL ASSETS LESS CURRENT LIABILITIES (3,724,433 ) (3,368,798 )
NET LIABILITIES (3,724,433 ) (3,368,798 )
CAPITAL AND RESERVES
Called up share capital 8 62,100 62,100
Profit and Loss Account (3,786,533 ) (3,430,898 )
SHAREHOLDERS' FUNDS (3,724,433) (3,368,798)
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Philip Ellin
Director
15 September 2025
The notes on pages 2 to 4 form part of these financial statements.
Page 1
Page 2
Niagara Therapy(U.K.)Limited
Notes to the Financial Statements
For The Year Ended 31 December 2024
Notes to the Financial Statements
1. General Information
Niagara Therapy(U.K.)Limited is a private company, limited by shares, incorporated in England & Wales, registered number 00857402 . The registered office is Unit 1 Colomendy Industrial Estate, Rhyl Road, Denbigh, Denbighshire, Clwyd, LL16 5TS.
The presentation currency of the financial statements is the Pound Sterling (£).
Accounts are rounded to the nearest pound.
The accounts represent the company as an individual entity.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The company's business activities, together with the factors likely to affect its future development and position, are set out in the Business Review section of the Directors' report in the consolidated financial statements.
The company had net liabilities at the end of the year however it is expected to continue to generate positive cash flows on its own accounts for the foreseeable future. The company participates in the group's centralised treasury arrangements and so shares banking arrangements with its parent and fellow subsidiaries.
The directors, having assessed the responses of the directors of the company's parent NHC Holdings Limited to their enquiries have no reason to believe that a material uncertainty exists that may cast significant doubt about the ability of the NHC Holdings Limited group to continue as a going concern or its ability to continue with the
current banking arrangements.
On the basis of their assessment of the company's financial position and of the enquiries made of the directors of NHC Holdings Limited, the company directors have a reasonable expectation that the company will be able to continue in the operational existence for the foreseeable future. Thus the going concern basis of accounting in
preparing the annual financial statements has been used.
The ultimate parent company NHC Holdings Limited has confirmed its intention to support the company in meeting its liabilities as they fall due, and consequently the financial statements have been prepared on the going concern basis.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Motor Vehicles 25% on cost
Fixtures & Fittings at varying rates on cost
2.5. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.6. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
Page 2
Page 3
Niagara Therapy(U.K.)Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
3. Average Number of Employees
Average number of employees, including directors, during the year was: 8 (2023: 8)
8 8
4. Tangible Assets
Motor Vehicles Fixtures & Fittings Total
£ £ £
Cost
As at 1 January 2024 1,654 71,146 72,800
As at 31 December 2024 1,654 71,146 72,800
Depreciation
As at 1 January 2024 1,654 71,146 72,800
As at 31 December 2024 1,654 71,146 72,800
Net Book Value
As at 31 December 2024 - - -
As at 1 January 2024 - - -
5. Investments
Unlisted
£
Cost
As at 1 January 2024 2
As at 31 December 2024 2
Provision
As at 1 January 2024 -
As at 31 December 2024 -
Net Book Value
As at 31 December 2024 2
As at 1 January 2024 2
The company owns 100% of the allotted share capital of Niagara Therapy (UK) Pension Trustees Limited, which is incorporated in England.
The subsidiary's principal activity is that of trustee to NHC Holdings Limited's pension schemes.
6. Debtors
2024 2023
£ £
Due within one year
Trade debtors 2,945 2,592
Amounts owed by group undertakings (55,636) -
Other debtors 16,258 24,710
(36,433 ) 27,302
Page 3
Page 4
Niagara Therapy(U.K.)Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 38,537 66,735
Bank loans and overdrafts 7,542 4,994
Amounts owed to group undertakings 3,619,493 3,307,207
Other creditors 22,095 16,806
Taxation and social security 1,185 1,210
3,688,852 3,396,952
8. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 62,100 62,100
9. Contingent Liabilities
The company has given composite cross guarantees relating to the bank borrowing of certain subsidiary companies. These borrowings amounted to £nil at the year end.
10. FRC's Ethical Standard - Provision Available for Small Entities
In common with other businesses of our size and nature we use our auditors to prepare and submit returns to the tax authorities and assist with the preparation of the financial statements.
11. Audit Information
The auditor's report on the accounts of Niagara Therapy(U.K.)Limited for the year ended 31 December 2024 was unqualified.
The auditor's report was signed by K Wood (Senior Statutory Auditor) for and on behalf of JWR Audit Limited , Statutory Auditor.
Page 4